New Delhi, Oct. 17 -- The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has undertaken Trade Margin Rationalisation (TMR) of 137 identified non-scheduled anti-cancer drugs in public interest to address excessive trade margins, make cancer treatment more affordable, and improve access to anti-cancer medicines.

The intervention is expected to bring down the MRP of the identified non-scheduled anti-cancer drugs by up to 70%, depending on their existing price structures.

According to a release by the Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals, The intervention builds upon the success of NPPA's 2019 pilot TMR exercise, under which tr...